PDI Reports 2009 Third Quarter Financi...(Revenue net $21041 $...),Health

Date:11/5/2009

Revenue, net $21,041 $24,496 $60,863 $87,124 Cost of services 14,182 24,084 42,152 74,423 ------ ------ ------ ------ Gross profit 6,859 412 18,711 12,701 Compensation expense 5,774 5,696 17,820 19,006 Other selling, general and administrative expenses 4,431 4,305 12,690 12,892 Facilities realignment 1,220 - 3,030 - ----- - ----- - Total operating expenses 11,425 10,001 33,540 31,898 ------ ------ ------ ------ Operating loss (4,566) (9,589) (14,829) (19,197) Other income, net 30 629 194 2,579 -- --- --- ----- Loss before income tax (4,536) (8,960) (14,635) (16,618) Provision for income tax 26 44 477 923 -- -- --- --- Net loss $(4,562) $(9,004) $(15,112) $(17,541) ======= ======= ======== ======== Loss per share of common stock: Basic $(0.32) $(0.63) $(1.06) $(1.23) Diluted $(0.32) $(0.63) $(1.06) $(1.23) Weighted average number of common shares and common share equivalents outstanding: Basic 14,216 14,243 14,216 14,253 Diluted 14,216 14,243 14,216 14,253 Segment Data (Unaudited) (in thousands) Product Sales Marketing Commercial-
'/>"/>

SOURCE PDI, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11
Related medicine technology :

1. CareFusion Reports First Quarter Results, Raises Full-Year Outlook
2. Symmetry Medical Reports Third Quarter 2009 Financial Results
3. NxStage(R) Reports Third Quarter 2009 Financial Results and Raises Revenue Guidance for Fiscal 2009
4. GSI Group Inc. Announces NASDAQ Delisting and Reports Progress on Revenue Recognition Review and Preliminary Third Quarter 2009 Bookings and Cash Balance
5. Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
6. HeartWare International Reports Third Quarter Revenues of $7.5 Million
7. Varian, Inc. Reports Fourth Quarter 2009 Results
8. Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent
9. Medivation Reports Third Quarter 2009 Financial Results and Provides Corporate Update
10. Cambrex Reports Third Quarter 2009 Results
11. Regeneron Reports Third Quarter 2009 Financial and Operating Results